Can 13-multiplex cytokine profiles predict early-stage CRS and irAEs in immunoncology?

The issue for detecting in daily routine the 13 cytokine multiplex protocol can help clinicians to handle much better cancer patients in order to adust their treatments for managing much better patients to live longer and with dignity?

Post an Answer

Sign In to Answer

There are currently no answers.

cancer markers and prediction of treatment and managments of cancer patients?

Posted 09/08/26
Does blocking NLRP3 and RIPK1/RIPK3 prevent both ferroptosis and necroptosis in radiation brain injury?

Posted 07/30/26
What is the optimal vaccine schedule for children?

Posted 08/14/26
For a change in the peer-reveiwing as an urgent need?

Answered 04/09/26
Rheumatoid Arthritis affects around 18 million people globally and has no known cure. DMARDs help control symptoms but don’t cure the disease. What traditional remedies are used for RA in your area?

Answered 07/29/25
Browse All Pings

Type

Public

Status

Published

Bounty

1 Ping Credit

Created

09/08/2026

Answer Count

0

Vote Count

0

Creator

Ioannis K. Toliopoulos

Tags

Biomarkers Carcinogenesis Cell biology Immunology